Korea Institute of Science and Technology

Medicinal Bioconvergence Research Center

Curebio Therapeutics

Snu Rdb Foundation

Neomics Co., Ltd.

Exozum Inc.

Min Chul Park

Sunghoon Kim

Seok Pil Lee

Jae Hun Kim

Young Min Jhon

Deok Ha Woo

Min Ah Seo

Taik Jin Lee

Joon Kui Ahn

Yong Soo Kim

Sun Ho Kim

Young Tae Byun

Chul Ki Kim

Younha Kim

Sung Hoon Kim

Dae Yeon Kim

Ji Hoon Kang

Ki Hyuk Kim

Jong Wook Hong

Joon-Sung Park

Soo Jeong Shin

Woon Jo Cho

Myung Suk Chun

Hyun Woo Ko

Peter Charles Goughnour

Dae Hwan Ahn

Jung Gyn Cho

Dae Young Han

Byung Woo Han

Jun Yong Choi

Sung Jin Cho

Ho Dong Lee

Kyul Ko

Joon Mo Ahn

Hyeon Na Han

Yeong Seon Choe

The present invention relates to novel fragments of AIMP1 protein and a composition for improving alopecia and promoting hair growth comprising the same, more specifically it relates to a polypeptide consisting of 4 to 21 consecutive amino acids from the amino acid sequence of SEQ ID NO: 1, wherein the polypeptide comprises the 28to 31amino acid residue (KEKA) of amino acid sequence of SEQ ID NO: 1, or a polypeptide consisting of an amino acid sequence having 70% or more sequence homology with the polypeptide; a polynucleotide encoding the polypeptide; a pharmaceutical, cosmetic and food composition for improving alopecia and promoting hair growth comprising the polypeptide.

AIMP1 protein fragment and hair growth-promoting composition containing same as active ingredient

The present invention relates to a colorectal cancer diagnostic composition and method for detecting a diagnostic marker, more specifically to a colorectal cancer diagnostic composition comprising one or more mRNAs selected from the group consisting of lysyl-tRNA synthetase (KRS) and aminoacyl-tRNA synthetase complex-interacting multifunctional protein 1 (AIMP1) of a preparation for measuring protein expression levels thereof, and a method for detecting a marker form a sample obtained from a test subject in order to provide information necessary for diagnosing colorectal cancer. The colorectal cancer diagnostic marker comprising KRS and AIMP1, according to the present invention, has raised expression levels of same in the serum of a colorectal cancer patient in comparison to a normal control group. Therefore, whether colorectal cancer is present can be accurately and rapidly determined by measuring the expression levels of one or more markers selected from the group consisting of KRS and AIMP1.

Colorectal cancer diagnostic composition, and method for detecting diagnostic marker

A user wears a virtual reality mask (VR mask) () and then watches a virtual reality image. The VR mask () blocks light incident from the outside. When the user wears the VR mask (), the user cannot discover an obstacle () positioned outside the VR mask (). The user may collide with the obstacle () and may be injured by the obstacle (). Accordingly, in order to prevent injury to the user who uses the VR mask (), it is necessary to make the user recognize the obstacle () positioned outside the VR mask (). In order to recognize an obstacle, a virtual reality image and the obstacle may be displayed together, or the amount of light incident from the outside may be adjusted.

Method and apparatus for displaying virtual reality image

Fragments of ARS-interacting multi-functional protein 1 (AIMP1) protein and a composition comprising the same as an active ingredient for preventing skin-aging, anti-wrinkle, and improving skin flexibility or elasticity are described.

AIMP1 protein fragment and skin-protecting composition containing same as active ingredient

A particle separation apparatus, according to an embodiment of the present invention, may comprise: a first input flow path into which a first fluid containing a plurality of particles of different sizes is introduced; a second input flow path into which a second fluid not containing particles is introduced; a connection flow path and the second input flow path so that a third fluid in which the first fluid and the second fluid are mixed movies; a plurality of discharge flow paths where the plurality of particles which come out through the other end of the connection flow path are separated and discharged according to the size of the particles; and a branch flow path where at least a part of the third fluid which comes out through the other end of the connection flow path is discharged.

Particle separation apparatus and particle separation method

A polypeptide having chemokine activity mediated by binding to C-C chemokine receptor type 3 (CCR3) comprising SEQ ID NO: 1 and uses thereof are described.

Polypeptide having chemokine activity and uses thereof

The present invention relates to nanoparticles comprising aminoacyl tRNA synthetase and an anticancer composition comprising the same and, specifically, to nanoparticles which comprise glycyl-tRNA synthetase (GRS), leucyl-tRNA synthetase (LRS), and isoleucyl-tRNA synthetase (IRS), and have anticancer or immunostimulating activity; a pharmaceutical composition for preventing or treating cancer, comprising the nanoparticles as an active ingredient; a composition for immunostimulation; and a method for preparing the nanoparticles.

Nanoparticles comprising aminoacyl tRNA synthetase and anticancer composition comprising same

Provided is an extreme ultra-violet (EUV) beam generation apparatus using multi-gas cell modules in which a gas is prevented from directly flowing into a vacuum chamber by adding an auxiliary gas cell serving as a buffer chamber to a main gas cell, a diffusion rate of the gas is decreased, a high vacuum state is maintained, and a higher power EUV beam is continuously generated.

Apparatus for generating extreme ultra-violet beam using multi-gas cell modules

Provided is a single pulse laser apparatus. The apparatus including a resonator having a first mirror, a second mirror, a gain medium, and electro-optic modulators (EOMs) which perform each mode-locking and Q-switching, the apparatus includes a photodiode which measures laser light that oscillates from the resonator, a synchronizer which converts an electrical signal generated by measuring the laser light into a transistor-transistor logic (TTL) signal, a delay unit which sets a latency determined in order to synchronize a mode-locked pulse with a Q-switched pulse to the TTL signal, and outputs a trigger TTL signal according to the latency, and a Q-driver which inputs the trigger TTL signal to the EOM which performs Q-switching, and causes the EOM to operates.

Single pulse laser apparatus

The present invention relates to a novel method of screening an agent for preventing or treating cancer using glycyl-tRNA synthetase (GRS) and cadherin (CDH). More particularly, it relates to a method of screening and test agent which modulates the binding level of GRS or their fragment with CDH. As can be seen foregoing, the present invention relates to a novel use of GRS and CDH and provides a method of screening an agent for preventing or treating cancer. The method may be used for developing novel agent for treatment of various cancer.

Method for screening an agent preventing or treating cancer using glycyl-tRNA synthetase and cadherin

Provided are an apparatus and method for calibrating an extreme ultraviolet (EUV) spectrometer in which a wavelength of a spectrum of EUV light used for EUV lithography and mask inspection technology can be measured accurately.

Apparatus and method for calibrating extreme ultraviolet spectrometer

Provided is a pulse laser apparatus for generating laser light. The apparatus includes a first mirror and a second mirror which are disposed at both ends of a resonator and configured to reflect the laser light, a gain medium disposed between the first and second mirrors and configured to amplify and output light incident from an outside, an etalon configured to adjust a pulse width of the laser light, and an acousto-optic modulator disposed between the first and second mirrors and configured to form a mode-locked and Q-switched signal from the laser light, in which some of the laser light is output through either the first or second mirror to outside the resonator.

Pulse laser apparatus

Provided is a three-dimensional (3D) display system. The 3D display system synthesizes a 3D image and position information data of an observer obtained through a camera with an optimal viewing area image with respect to horizontal and vertical directions of a display panel in a 3D space, and displays the synthesized image on the display panel such that the observer can visually know an optimal viewing area. Accordingly, the 3D display system enables the observer to visually check the optimal viewing area with ease and induces the observer to move to a position in the optimal viewing area.

3D display system

The present invention is related to a anticancer composition comprising full length GRS protein or a fragment thereof, a nucleic acid encoding the GRS protein or a fragment thereof. Since the GRS proteins or fragments thereof have activity to induce apoptosis of cancer cell specifically, a composition comprising the GRS proteins or fragments thereof or a nucleic acid encoding thereof may be useful to treatment of cancer.

Uses of GRS proteins or fragments thereof

Growing community of inventors

Seoul, South Korea

Min Chul Park